You are here

News and Media

Erik Jacobs
News / 11.2.18
Melanoma immunotherapy from two cells' points of view, drugging undruggable cancer targets, listening to gut cells talk to each other, and more.Read more
Susanna M. Hamilton, Broad Communications
News / 11.2.18
Laboratory study suggests that thalidomide-like drugs could be designed to target a broad array of transcription factors, and open a new landscape of cancer drug development.Read more
Susanna M. Hamilton, Broad Communications
News / 11.1.18
A subset of intestinal stem cells communicate with T helper cells, which in turn may influence stem cells' state through the cytokines they produce.Read more
News / 11.1.18
Study may help predict patient response, reduce treatment resistanceRead more
News / 11.1.18
Researchers identify a molecular strategy that human melanoma cells use to resist immunotherapy, and develop a new approach to combat the resistance in mouse modelsRead more